Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


India: More than 401,000 New COVID Cases in 24 Hours

VOA News

   India's health ministry Saturday reported more than 401,000 new COVID
   infections and nearly 4,200 deaths in the previous 24-hour period.

   Public health experts believe the staggering statistics in India are
   likely higher and the surge of cases may not reach its peak until the
   end of May.

   India's main opposition leader, Rahul Gandhi, urged Prime Minister
   Narendra Modi in a letter Friday to implement a national lockdown,
   accelerate the vaccination campaign and increase tracking of the virus
   and its mutations.

   "Allowing the uncontrollable spread of the virus in our country will be
   devastating not only for our people but also for the rest of the
   world," Gandhi said.

   Britain has declared a COVID variant from India as a "variant of
   concern."

   Pope Francis said that he supports the temporary suspension of vaccine
   patents, according to news reports. He added that market forces, as it
   relates to the vaccines, must not predominate.

   The World Health Organization Friday approved a COVID-19 vaccine
   developed in China for emergency use worldwide.

   The vaccine, from China's state-owned drugmaker, Sinopharm, is the
   first vaccine manufactured by a non-Western country to be endorsed by
   WHO.

   Friday's move was also the first time the global public health group
   granted emergency approval to a Chinese vaccine for an infectious
   disease.

   The Sinopharm COVID-19 vaccine has already been administered to
   hundreds of millions of people in China and in other parts of the
   world, along with a second Chinese vaccine.

   WHO's decision allows the Sinopharm vaccine to be included in the
   COVID-19 Vaccines Global Access, or COVAX, an initiative to distribute
   vaccines to mainly low-income countries.

   WHO has said it could decide on China's second main vaccine, made by
   Sinovac Biotech, as early as next week.